Allergan's eye care pharmaceutical products generated a 22.1 percent sales increase to $492.2 million for the first quarter, with a 17.4 percent rise in local currencies. Total revenues went up by 23 percent to $1,061 million and net income more than doubled to $111 million, compared with $44 million in the first quarter of 2007.